Single- and Multiple-Dose Pharmacokinetics and Safety of the SARS-CoV-2 3CL Protease Inhibitor RAY1216: a Phase 1 Study in Healthy Participants
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY（2025）
Key words
RAY1216,pharmacokinetics,safety,3CL protease inhibitor,COVID-19
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined